The handwriting is on the wall: there will soon be a drug for AKI

Nat Rev Nephrol. 2019 Feb;15(2):65-66. doi: 10.1038/s41581-018-0095-2.

Authors

John A Kellum^{1

2}, Dana Y Fuhrman^{3

4

5}

Affiliations

¹ Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, PA, USA. kellum@pitt.edu.
² Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA. kellum@pitt.edu.
³ Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, PA, USA.
⁴ Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
⁵ Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

PMID: 30546091
DOI: 10.1038/s41581-018-0095-2

No abstract available

Publication types

Review

MeSH terms

Acute Kidney Injury / drug therapy*
Acute Kidney Injury / etiology
Acute Kidney Injury / metabolism
Biomarkers / metabolism
Clinical Trials as Topic
Drug Discovery / methods
Drug Discovery / trends*
Humans
Urological Agents / therapeutic use*

Substances

Biomarkers
Urological Agents